Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 35,821 | 39,536 | 38,145 | 34,292 | 32,688 |
| Cost of Goods | 17,687 | 16,513 | 17,333 | 13,318 | 15,944 |
| Gross Profit | 18,134 | 23,023 | 20,812 | 20,974 | 16,744 |
| Operating Expenses | 27,944 | 22,236 | 11,965 | 20,034 | 35,641 |
| Operating Income | -9,123 | 1,300 | 9,180 | 1,258 | -17,953 |
| Other Income | -47 | -48 | -50 | -43 | -184 |
| Pre-tax Income | -9,170 | 1,252 | 9,130 | 1,215 | -18,137 |
| Income Tax | -3,377 | 694 | 2,599 | -1,623 | -2,481 |
| Net Income Continuous | -5,793 | 558 | 6,531 | 2,838 | -15,656 |
| Net Income | $-5,793 | $558 | $6,531 | $2,838 | $-15,656 |
| EPS Basic Total Ops | -0.40 | 0.04 | 0.45 | 0.20 | -1.11 |
| EPS Basic Continuous Ops | -0.40 | 0.04 | 0.45 | 0.20 | -1.10 |
| EPS Diluted Total Ops | -0.41 | 0.04 | 0.45 | 0.20 | -1.10 |
| EPS Diluted Continuous Ops | -0.40 | 0.04 | 0.45 | 0.20 | -1.10 |
| EBITDA(a) | $-4,572 | $6,334 | $14,891 | $7,344 | $13,610 |